Adaptin Bio (APTN) Change in Account Payables (2023 - 2026)
Adaptin Bio's (APTN) quarterly Change in Account Payables came in at $260275.0 in Q2 2026, down 23.34% year-over-year from $339513.0 in Q2 2025, and up 284.88% quarter-over-quarter from -$140781.0 in Q1 2026.
Powered by 
Analysis
Adaptin Bio (APTN) Change in Account Payables (2023 - 2026) Analysis & Trends
Adaptin Bio has disclosed Change in Account Payables across 4 years of filings, most recently posting $260275.0 for Q2 2026.
- In Q2 2026, Change in Account Payables fell 23.34% year-over-year to $260275.0; the TTM figure through Jun 2026 stood at $965015.0 (up 85.3% YoY), while the FY2025 annual figure was $496910.0, down 54.02% from the prior year.
- Change in Account Payables came in at $260275.0 for Q2 2026 at Adaptin Bio, up from -$140781.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $671507.0 in Q3 2025 to a low of -$688124.0 in Q1 2025.
- Average Change in Account Payables over 4 years is $142137.3, with a median of $217144.5 recorded in 2025.
- Year-over-year, Change in Account Payables surged 10241.25% in 2024 and plunged 347.62% in 2025.
- Over 4 years, Change in Account Payables stood at $4250.0 in 2023, then jumped by 10015.27% to $429899.0 in 2024, then sank by 59.52% to $174014.0 in 2025, then surged by 49.57% to $260275.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $260275.0 in Q2 2026, -$140781.0 in Q1 2026, and $174014.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 3.06 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -11.82 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 2.90 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 625,000.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 1.21 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 2.84 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -19.39 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 1.57 Mn |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - | 260,275.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 260,275.00 |
| Mar 31, 2026 | -140,781.00 |
| Dec 31, 2025 | 174,014.00 |
| Sep 30, 2025 | 671,507.00 |
| Jun 30, 2025 | 339,513.00 |
| Mar 31, 2025 | -688,124.00 |
| Dec 31, 2024 | 429,899.00 |
| Sep 30, 2024 | 439,503.00 |
| Jun 30, 2024 | -66,558.00 |
| Mar 31, 2024 | 277,900.00 |
| Dec 31, 2023 | 4,250.00 |
| Sep 30, 2023 | 4,250.00 |